New Test Rapidly Detects Trace Pesticides in Foods
|
By LabMedica International staff writers Posted on 20 Nov 2009 |
A "dipstick” test to identify small amounts of pesticides in foods and beverages produces results in minutes rather than hours, by means of a color changing paper-strip.
Researchers at McMaster University (Hamilton, ON, USA) developed the reagent-less, bioactive paper-based solid-phase biosensor, which can be used for the detection of acetylcholinesterase (AChE) inhibitors, which include organophosphate pesticides. The assay strip is composed of a paper support strip, onto which AChE and a chromogenic substrate, indophenyl acetate (IPA) are entrapped using biocompatible sol-gel derived silica inks in two different zones (the sensing and substrate zones). The assay protocol involves first introducing the sample to the sensing zone via lateral flow of a pesticide-containing solution. Following an incubation period, the opposite end of the paper support is placed into distilled deionized water (ddH2O) to allow lateral flow in the opposite direction, thus moving the paper-bound IPA to the sensing area and initiating enzyme catalyzed hydrolysis of the substrate, which causes a yellow-to-blue color change.
The modified sensor is able to detect pesticides without the use of any external reagents, with excellent detection limits and rapid response times of approximately five minutes. In field tests, the sensor strip showed negligible matrix effects in the detection of pesticides in spiked milk and apple juice samples. Bioactive paper-based assays on pesticide residues collected from food samples showed good agreement with a conventional mass spectrometric assay method. The study describing the biosensor was published in the November 1, 2009, issue of Analytical Chemistry.
"The bioactive paper assay should, therefore, be suitable for rapid screening of trace levels of organophosphate and carbamate pesticides in environmental and food samples,” concluded lead author John Brennan, Ph.D., and colleagues of the department of chemistry and chemical biology.
Conventional tests for detecting pesticides tend to use complex mass spectrographic equipment, and in some cases can take several hours to produce results. A growing need for cheaper, more convenient, and more eco-friendly tests for pesticides is being seen, particularly in the food industry and in developing countries or remote areas that may lack access to expensive testing equipment and electricity.
Related Links:
McMaster University
Researchers at McMaster University (Hamilton, ON, USA) developed the reagent-less, bioactive paper-based solid-phase biosensor, which can be used for the detection of acetylcholinesterase (AChE) inhibitors, which include organophosphate pesticides. The assay strip is composed of a paper support strip, onto which AChE and a chromogenic substrate, indophenyl acetate (IPA) are entrapped using biocompatible sol-gel derived silica inks in two different zones (the sensing and substrate zones). The assay protocol involves first introducing the sample to the sensing zone via lateral flow of a pesticide-containing solution. Following an incubation period, the opposite end of the paper support is placed into distilled deionized water (ddH2O) to allow lateral flow in the opposite direction, thus moving the paper-bound IPA to the sensing area and initiating enzyme catalyzed hydrolysis of the substrate, which causes a yellow-to-blue color change.
The modified sensor is able to detect pesticides without the use of any external reagents, with excellent detection limits and rapid response times of approximately five minutes. In field tests, the sensor strip showed negligible matrix effects in the detection of pesticides in spiked milk and apple juice samples. Bioactive paper-based assays on pesticide residues collected from food samples showed good agreement with a conventional mass spectrometric assay method. The study describing the biosensor was published in the November 1, 2009, issue of Analytical Chemistry.
"The bioactive paper assay should, therefore, be suitable for rapid screening of trace levels of organophosphate and carbamate pesticides in environmental and food samples,” concluded lead author John Brennan, Ph.D., and colleagues of the department of chemistry and chemical biology.
Conventional tests for detecting pesticides tend to use complex mass spectrographic equipment, and in some cases can take several hours to produce results. A growing need for cheaper, more convenient, and more eco-friendly tests for pesticides is being seen, particularly in the food industry and in developing countries or remote areas that may lack access to expensive testing equipment and electricity.
Related Links:
McMaster University
Latest Clinical Chem. News
- FDA-Approved Test Identifies Low Risk of Large Esophageal Varices in Cirrhosis
- Blood Protein Signature Diagnoses Pediatric IBD and Distinguishes Subtypes
- Blood Test Detects More High-Risk Prostate Cancers Than PSA
- Rapid Blood Test Aids Diagnosis of Acute Ischemic Stroke
- Blood-Based Alzheimer’s Testing Platform Offers Rapid Results
- Maternal Blood Biomarkers Identify Risk of Preterm and Early-Term Birth
- Simple Oral Swab Monitors Persistent Inflammation in Primary Ciliary Dyskinesia
- Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features
- Plasma Vitamin C Levels Associated with Brain Structure and Connectivity in Aging
- Mass Spectrometry Detects Tumor Metabolites for Cancer Monitoring
- Urinary Biomarker Assay Predicts Kidney Disease Progression Beyond Standard Measures
- Saliva-Based Test Detects Biochemical Signs of Sleep Loss
- Simple Dual-Tau Blood Test Detects and Stages Alzheimer’s Disease
- Alzheimer’s Blood Biomarkers Linked to Early Cognitive Differences Before Dementia
- Urine-Based Test Shows Promise for Autism Screening in Children
- Blood-Based Sensor Detects Early Signs of Alzheimer’s and Parkinson’s
Channels
Clinical Chemistry
view channel
FDA-Approved Test Identifies Low Risk of Large Esophageal Varices in Cirrhosis
Chronic liver disease contributes substantially to mortality, and clinicians routinely screen adults with compensated cirrhosis for varices to prevent bleeding. However, endoscopy is invasive and reso... Read more
Blood Protein Signature Diagnoses Pediatric IBD and Distinguishes Subtypes
Confirming pediatric inflammatory bowel disease (IBD) often requires imaging, endoscopy, and histopathology, prolonging time to diagnosis. Reliable, noninvasive blood tests remain an unmet need in routine... Read moreMolecular Diagnostics
view channel
New Sequencing Platform Delivers Same-Day Whole-Genome Results
Roche (Basel, Switzerland) has introduced AXELIOS 1, a next‑generation single‑molecule sequencing platform powered by proprietary sequencing by expansion (SBX) technology. The system is positioned to combine... Read more
New Molecular Marker Helps Predict Multiple Myeloma Prognosis
Multiple myeloma is a bone marrow cancer marked by resistance to therapy and frequent relapse, complicating long-term disease control. Better molecular markers are needed to refine risk assessment and... Read moreHematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read moreImmunology
view channel
Anti-Lipid Antibody Biomarkers May Identify Early Lyme Disease and Persistent Symptoms
Lyme disease is often missed during its earliest and most treatable stage, while current serologic assays cannot distinguish active infection from prior exposure. Nearly half a million Americans are diagnosed... Read more
Emergency Department Opt-Out Testing Program Identifies Undiagnosed HIV
Undiagnosed HIV continues to drive avoidable morbidity and transmission, with many people identified only after substantial immune damage has occurred. In England, about one in 20 people living with HIV... Read more
Immune Biomarkers Could Identify Risk of Chronic Critical Illness on ICU Admission
Severe traumatic injury can trigger immune and organ dysfunction that complicates recovery in the intensive care unit. A subset of patients develop chronic critical illness, defined as dependence on intensive... Read moreMicrobiology
view channel
Rapid Gastrointestinal PCR Panels Deliver One-Hour Results
Acute infectious gastroenteritis remains a major cause of illness worldwide, especially in young children, older adults, and immunocompromised patients. Nonspecific symptoms such as diarrhea, vomiting,... Read more
H. pylori Screening Within Colorectal Program Aids Gastric Cancer Prevention
Health systems increasingly rely on economic evidence to guide cancer prevention strategies. For gastric cancer, selecting screening approaches that can integrate with existing programs is a key policy question.... Read more
Machine Learning Reveals Consistent Gut Microbiome Patterns in Colorectal Cancer
Colorectal cancer has been repeatedly linked to alterations in the gut microbiome, yet findings have often varied across small, heterogeneous studies. Reproducibility has been limited by differing sequencing... Read morePathology
view channel
AI Pathology Tool Predicts Immunotherapy Response in Rare Cancers
Immunotherapy has transformed care for select malignancies, yet predicting which patients with rare cancers are most likely to benefit remains challenging. Clinicians often have only limited biomarkers... Read more
Uncertainty-Aware AI Tool Improves Digital Pathology for Cancer Subtyping
Reliable histologic subtyping guides therapy selection in oncology, yet diagnostic workflows grow more complex as whole-slide imaging and artificial intelligence (AI) expand. A persistent obstacle to clinical... Read moreTechnology
view channel
National Rare Disease Registry Standardizes Genetic and Clinical Data for Coordinated Care
Rare diseases collectively impose a significant clinical burden despite their individual rarity, often involving multisystem presentations and prolonged diagnostic journeys. Limited specialist expertise... Read more
AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
Oncology teams must manage growing volumes of genomic data, rapidly evolving clinical trial options, and frequently updated care guidelines, all within tight clinic schedules. Translating complex tumor... Read moreIndustry
view channel
Eurobio Scientific Completes Acquisition of CareDx Lab Products Division
Eurobio Scientific has closed the acquisition of CareDx AB in Sweden and its fully owned subsidiaries in the United States and Australia that constitute CareDx’s Lab Products division. The business will... Read more
Blood-Based CRISPR Test for Tuberculosis Gains Regulatory Approval in Colombia
Colombia remains a high-priority setting for tuberculosis, with a growing need for diagnostics that complement existing testing strategies and improve access to earlier diagnosis. Solutions that function... Read more








